PO.CL01.19 · 临床研究

HPV阳性宫颈疾病中血液和组织来源细胞外囊泡特征

Blood- and tissue-derived extracellular vesicle signatures in HPV-positive cervical disease

编号 2544 展板 19 时间 4/20 09:00–12:00 区域 Section 44 主讲 Angie Rivera-Ramos, BS
分会场 Early Detection Biomarkers 2
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Angie Gabriela Rivera-Ramos1, Mariano Molina Beitia2, Rafael Parra-Medina3, Alba Lucía Combita-Rojas3, Metoboroghene Mowoe4, Daniel Hagey4

1Department of Medicine, National University of Colombia, Bogota, Colombia,2Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden,3Pathology, Instituto Nacional de Cancerología, Bogota, Colombia,4Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

摘要 Abstract

中文摘要
背景:细胞外囊泡(EVs)是宫颈疾病检测生物标志物的有前景来源。然而,结合液体活检和实体活检的最佳EV分离策略仍未得到充分探索,尤其是在资源多变的临床环境中。 方法:我们在一个哥伦比亚HPV阳性女性临床队列中实施了双源EV分离方法。从17名参与者(9例鳞状上皮内病变[SIL]病例,8例对照)中收集了血浆样本和实体活检。血浆来源的EV直接分离,而组织来源的EV通过经过优化的酶促和机械解离方案建立的原代成纤维细胞培养获得。使用纳米颗粒跟踪分析、透射电子显微镜和流式细胞术免疫表型对EV进行表征。制备mRNA和蛋白货物用于RNA测序和蛋白质组学分析。 结果:双源方法成功地从血浆和组织样本中获得了EV,其质量和数量适合下游分析。纳米颗粒跟踪分析证实了预期的尺寸分布,而透射电子显微镜验证了培养细胞的EV形态。流式细胞术免疫表型鉴定了特征性EV表面标志物。优化的组织解离工作流程生成了能够产生可分析EV的稳健原代培养物。血浆来源EV的初步mRNA测序揭示了能够区分SIL病例与对照并显示与病变分级相关的候选分子特征。 结论:这种双源EV策略在哥伦比亚临床环境中是可行的,并支持开发用于HPV相关宫颈疾病早期检测和风险分层的液体活检生物标志物。该方法能够从互补的生物学来源进行全面的分子分析,值得在更大规模队列中进一步验证。
查看英文原文 English abstract
Background: Extracellular vesicles (EVs) represent promising sources of biomarkers for cervical disease detection. However, optimal EV isolation strategies combining liquid and solid biopsies remain underexplored, particularly in resource-variable clinical settings. Methods: We implemented a dual-source EV isolation approach in a Colombian clinical cohort of HPV-positive women. Plasma samples and solid biopsies were collected from 17 participants (9 squamous intraepithelial lesion [SIL] cases, 8 controls). Plasma-derived EVs were isolated directly, while tissue-derived EVs were obtained from primary fibroblast cultures established through optimized enzymatic and mechanical dissociation protocols. EVs were characterized using nanoparticle tracking analysis, transmission electron microscopy, and flow cytometry immunophenotyping. mRNA and protein cargo were prepared for RNA sequencing and proteomic analysis. Results: The dual-source approach successfully yielded EVs from both plasma and tissue samples with appropriate quality and quantity for downstream analysis. Nanoparticle tracking analysis confirmed expected size distributions, while transmission electron microscopy validated EV morphology from cultured cells. Flow cytometry immunophenotyping identified characteristic EV surface markers. The optimized tissue dissociation workflow generated robust primary cultures capable of producing analyzable EVs. Preliminary mRNA sequencing of plasma-derived EVs revealed candidate molecular signatures that distinguished SIL cases from controls and showed association with lesion grade. Conclusions: This dual-source EV strategy is feasible in Colombian clinical settings and supports the development of liquid biopsy biomarkers for early detection and risk stratification of HPV-related cervical disease. The approach enables comprehensive molecular profiling from complementary biological sources, warranting further validation in larger cohorts.
利益披露 Disclosure
A. Rivera-Ramos, None.. M. Molina Beitia, None.. R. Parra-Medina, None.. A. Combita-Rojas, None.. M. Mowoe, None.. D. Hagey, None.

← 返回 AACR 2026 检索